TRVI - Financial Reports List - Trevi Therapeutics, Inc. - IntrinsicAlpha

Trevi Therapeutics, Inc. TRVI

Healthcare - Biotechnology - NASDAQ - US

$ 6.145

-0.824 %

$ 594 M

Market Cap

-12.81

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-45.95%	-37.05%
Annual Report	FY	10-K	2024-12-31	0.00%	-64.84%	-51.89%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-72.02%	-55.74%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-72.88%	-58.54%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-70.32%	-57.42%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-42.10%	-34.21%
Annual Report	FY	10-K	2023-12-31	0.00%	0.30%	-13.43%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	6.87%	-7.61%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	11.26%	-7.19%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	12.66%	-7.66%

1